XML 14 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Class B Common Stock
Common Stock
Common Shares
Common Stock
Class B Common Stock
Capital Surplus
Retained Earnings
Retained Earnings
Common Shares
Retained Earnings
Class B Common Stock
Accumulated Other Comprehensive Loss
Balance at beginning of period at Aug. 26, 2023 $ 2,003,960     $ 1,510 $ 359 $ 99,303 $ 1,926,549     $ (23,761)
Balance at beginning as of period (in shares) at Aug. 26, 2023       15,104 3,590          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 42,325           42,325      
Change in fair value of derivatives [1] (12)                 (12)
Foreign currency translation (151)                 (151)
Dividends declared Common Stock   $ (4,993) $ (948)         $ (4,993) $ (948)  
Repurchase of Common Stock (255)         (10) (245)      
Repurchase of common stock (in shares)       (2)            
Share-based compensation, net [2] 244         244        
Share-based awards exercised, net [1] 3     $ 3            
Share-based awards exercised, net (in shares) [1]       26            
Balance at end of period at Nov. 25, 2023 2,040,173     $ 1,513 $ 359 99,537 1,962,688     (23,924)
Balance at end as of period (in shares) at Nov. 25, 2023       15,128 3,590          
Balance at beginning of period at Aug. 26, 2023 2,003,960     $ 1,510 $ 359 99,303 1,926,549     (23,761)
Balance at beginning as of period (in shares) at Aug. 26, 2023       15,104 3,590          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 100,839                  
Foreign currency translation 170                  
Balance at end of period at May. 25, 2024 2,075,608     $ 1,504 $ 359 103,097 1,994,279     (23,631)
Balance at end as of period (in shares) at May. 25, 2024       15,040 3,590          
Balance at beginning of period at Nov. 25, 2023 2,040,173     $ 1,513 $ 359 99,537 1,962,688     (23,924)
Balance at beginning as of period (in shares) at Nov. 25, 2023       15,128 3,590          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 20,457           20,457      
Change in fair value of derivatives [1] (34)                 (34)
Foreign currency translation 919                 919
Dividends declared Common Stock   (4,976) (948)         (4,976) (948)  
Repurchase of Common Stock (7,864)     $ (4)   (298) (7,562)      
Repurchase of common stock (in shares)       (45)            
Share-based compensation, net [2] 1,958         1,958        
Share-based awards exercised, net (in shares) [1]       4            
Balance at end of period at Feb. 24, 2024 2,049,685     $ 1,509 $ 359 101,197 1,969,659     (23,039)
Balance at end as of period (in shares) at Feb. 24, 2024       15,087 3,590          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 38,057           38,057      
Change in fair value of derivatives [1] 6                 6
Foreign currency translation (598)                 (598)
Dividends declared Common Stock   (4,961) (948)         (4,961) (948)  
Repurchase of Common Stock (7,844)     $ (5)   (311) (7,528)      
Repurchase of common stock (in shares)       (47)            
Share-based compensation, net [2] 2,211         2,211        
Balance at end of period at May. 25, 2024 2,075,608     $ 1,504 $ 359 103,097 1,994,279     (23,631)
Balance at end as of period (in shares) at May. 25, 2024       15,040 3,590          
Balance at beginning of period at Aug. 31, 2024 2,108,511     $ 1,500 $ 359 104,791 2,025,505     (23,644)
Balance at beginning as of period (in shares) at Aug. 31, 2024       15,000 3,590          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 43,105           43,105      
Change in fair value of derivatives [1] 41                 41
Foreign currency translation (4,936)                 (4,936)
Dividends declared Common Stock   (5,260) (996)         (5,260) (996)  
Repurchase of Common Stock (6,373)     $ (3)   (235) (6,135)      
Repurchase of common stock (in shares)       (34)            
Share-based compensation, net [2] (448)         (448)        
Share-based awards exercised, net [1] 3     $ 3            
Share-based awards exercised, net (in shares) [1]       33            
Shares converted       $ 3 $ (3)          
Shares converted (in shares)       32 (32)          
Balance at end of period at Nov. 30, 2024 2,133,647     $ 1,503 $ 356 104,108 2,056,219     (28,539)
Balance at end as of period (in shares) at Nov. 30, 2024       15,031 3,558          
Balance at beginning of period at Aug. 31, 2024 2,108,511     $ 1,500 $ 359 104,791 2,025,505     (23,644)
Balance at beginning as of period (in shares) at Aug. 31, 2024       15,000 3,590          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 107,244                  
Foreign currency translation (755)                  
Balance at end of period at May. 31, 2025 2,174,791     $ 1,494 $ 355 108,486 2,088,873     (24,417)
Balance at end as of period (in shares) at May. 31, 2025       14,936 3,553          
Balance at beginning of period at Nov. 30, 2024 2,133,647     $ 1,503 $ 356 104,108 2,056,219     (28,539)
Balance at beginning as of period (in shares) at Nov. 30, 2024       15,031 3,558          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 24,459           24,459      
Change in fair value of derivatives [1] 25                 25
Foreign currency translation (4,438)                 (4,438)
Dividends declared Common Stock   (5,251) (996)         (5,251) (996)  
Repurchase of Common Stock (6,155)     $ (3)   (231) (5,921)      
Repurchase of common stock (in shares)       (33)            
Share-based compensation, net [2] 2,264         2,264        
Share-based awards exercised, net [1] 1     $ 1            
Share-based awards exercised, net (in shares) [1]       8            
Balance at end of period at Mar. 01, 2025 2,143,556     $ 1,501 $ 356 106,141 2,068,510     (32,952)
Balance at end as of period (in shares) at Mar. 01, 2025       15,006 3,558          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 39,680           39,680      
Change in fair value of derivatives (84)                 (84)
Foreign currency translation 8,619                 8,619
Dividends declared Common Stock   $ (5,227) $ (995)         $ (5,227) $ (995)  
Repurchase of Common Stock (13,634)     $ (8)   (531) (13,095)      
Repurchase of common stock (in shares)       (76)            
Share-based compensation, net [2] 2,876         2,876        
Share-based awards exercised, net (in shares) [1]       1            
Shares converted       $ 1 $ (1)          
Shares converted (in shares)       5 (5)          
Balance at end of period at May. 31, 2025 $ 2,174,791     $ 1,494 $ 355 $ 108,486 $ 2,088,873     $ (24,417)
Balance at end as of period (in shares) at May. 31, 2025       14,936 3,553          
[1] These amounts are shown net of the effect of income taxes.
[2] These amounts are shown net of any shares withheld by the Company to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.